UBS Group
PBAXU

UBS Group’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

UBS Group’s Portfolio PBAXU Stock Details PBAXU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-992
Closed -$10K – 11385
2022
Q3 		$10K Hold
992
– – ﹤0.01% 8488
2022
Q2 		$10K Buy
992
+115
+13% +$1.16K ﹤0.01% 8043
2022
Q1 		$9K Sell
877
-60
-6% -$606 ﹤0.01% 8586
2021
Q4 		$9K Buy
+937
New +$9.48K ﹤0.01% 8957

Other funds holding PBAXU

YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return